Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds antigen or epitope whose amino acid sequence is...
Reexamination Certificate
2003-02-05
2009-12-08
Belyavskyi, Michail A (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds antigen or epitope whose amino acid sequence is...
C424S142100, C424S154100, C424S577000
Reexamination Certificate
active
07628988
ABSTRACT:
The invention features methods for increasing or maintaining the number of functional cells of a predetermined type, for example, insulin producing cells of the pancreas, blood cells, spleen cells, brain cells, heart cells, vascular tissue cells, cells of the bile duct, or skin cells, in a mammal (e.g., a human patient) that has injured or damaged cells of the predetermined type.
REFERENCES:
patent: 4309418 (1982-01-01), Green
patent: 4457916 (1984-07-01), Hayashi et al.
patent: 4495282 (1985-01-01), Ohnishi et al.
patent: 4677063 (1987-06-01), Mark et al.
patent: 4677064 (1987-06-01), Mark et al.
patent: 4681760 (1987-07-01), Fathman
patent: 4791101 (1988-12-01), Adolf
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4879226 (1989-11-01), Wallace et al.
patent: 4963354 (1990-10-01), Shepard et al.
patent: 4985241 (1991-01-01), Zimmerman et al.
patent: 5002876 (1991-03-01), Sreekrishna et al.
patent: 5059530 (1991-10-01), Oshima et al.
patent: 5139481 (1992-08-01), Faustman et al.
patent: 5215743 (1993-06-01), Singh et al.
patent: 5283058 (1994-02-01), Faustman
patent: 5288852 (1994-02-01), Yamada et al.
patent: 5370870 (1994-12-01), Wong
patent: 5487984 (1996-01-01), Allet et al.
patent: 5538854 (1996-07-01), Faustman
patent: 5560908 (1996-10-01), Satoh et al.
patent: 5593698 (1997-01-01), Weiner et al.
patent: 5783216 (1998-07-01), Faustman
patent: 5821337 (1998-10-01), Carter et al.
patent: 5843425 (1998-12-01), Sachs et al.
patent: 5843452 (1998-12-01), Wiedmann et al.
patent: 5874306 (1999-02-01), Beattie et al.
patent: 5919452 (1999-07-01), Le et al.
patent: 6046031 (2000-04-01), Ni et al.
patent: 6056952 (2000-05-01), Rosenberg
patent: 6159461 (2000-12-01), Besmer et al.
patent: 6165737 (2000-12-01), Wang et al.
patent: 6284879 (2001-09-01), Faustman
patent: 6414218 (2002-07-01), Faustman et al.
patent: 6491908 (2002-12-01), Rosenberg
patent: 6599710 (2003-07-01), Faustman
patent: 6617171 (2003-09-01), Faustman et al.
patent: 6660487 (2003-12-01), Faustman
patent: 6773705 (2004-08-01), Faustman et al.
patent: 6844011 (2005-01-01), Faustman
patent: 6866843 (2005-03-01), Habener et al.
patent: 6923959 (2005-08-01), Habener et al.
patent: 6984380 (2006-01-01), Faustman
patent: 2002/0106689 (2002-08-01), Faustman et al.
patent: 2002/0123472 (2002-09-01), Faustman
patent: 2003/0005469 (2003-01-01), Faustman et al.
patent: 2003/0031657 (2003-02-01), Habener et al.
patent: 2004/0028658 (2004-02-01), Faustman
patent: 2004/0031066 (2004-02-01), Faustman et al.
patent: 2004/0229785 (2004-11-01), Faustman
patent: 2005/0158288 (2005-07-01), Faustman
patent: 2005/0158302 (2005-07-01), Faustman et al.
patent: 2005/0244386 (2005-11-01), Habener et al.
patent: 2006/0062769 (2006-03-01), Habener et al.
patent: 2007/0116688 (2007-05-01), Faustman
patent: WO 95/24914 (1995-09-01), None
patent: WO 95/25533 (1995-09-01), None
patent: WO 97/08328 (1997-03-01), None
patent: WO 0053209 (2000-03-01), None
Atkinson et al. ., Nature, 1999, V.5, pp. 601-604.
Kaufman et al., J of Immunol. 1997, V.158, pp. 2435-2442).
Mestas et al J. of Immunology, 2004, 172, pp. 2731-2738.
Feldman et al Transplant. Proc. 1998, 30, 4126-4127.
Van Noort et al. International Review of Cytology, 1998.
Couzin Science, 2006, V.311, p. 1694.
Alison et al., “Hepatocytes from Non-hepatic Adult Stem Cells,” Nature 406:257 (2000).
Anderson et al., “Can Stem Cells Cross Lineage Boundries?” Nature Medicine 7:393-395 (2001).
Barres, “A New Role for Glia: Generation of Neurons!” Cell 97:667-670 (1999).
Bjornson et al., “Turning Brain into Blood: A Hematopoietic Fate Adopted by Adult Neural Stem Cells In Vitro,” Science 283(5401):534-537 (1999).
Brazelton et al., “From Marrow to Brain: Expression of Neuronal Phenotypes in Adult Mice,” Science 290(5497):1775-1779 (2000).
Bunting et al., “Enforced P-glycoprotein Pump Function in Murine Bone Marrow Cells Results in Expansion of Side Population Stem Cells In Vitro and Repopulating Cells In Vivo,” Blood 96:902-909 (2000).
Eglitis et al., “Hematopoietic Cells Differentiate Into Both Microglia and Macroglia in the Brains of Adult Mice,” Proc. Natl. Acad. Sci. U.S.A. 94(8):4080-4085 (1997).
Gage, “Mammalian Neural Stem Cells,” Science 287(5457):1433-1438 (2000).
Gage et al., “Multipotent Progenitor Cells in the Adult Dentate Gyrus,” J. Neurobiol. 36(2):249-266 (1998).
Gaur et al., “Induction of Islet Allotolerance in Nonhuman Primates,” Ann. NY Acad. Sci. 958:199-203 (2002).
Jackson et al., “Hematopoietic Potential of Stem Cells Isolated from Murine Skeletal Muscle,” Proc. Natl. Acad. Sci. U.S.A. 96:14482-14486 (1999).
Jiang et al., “Pluripotency of Mesenchymal Stem Cells Derived from Adult Marrow,” Nature 418:41-49(2002).
Johansson et al., “Identification of A Neural Stem Cell in the Adult Mammalian Central Nervous System,” Cell 96:25-34 (1999).
Kanzler and Dear, “Hox11 Acts Cell Autonomously in Spleen Development and Its Absence Results in Altered Cell Fate of Mesenchymal Spleen Precursors,” Devel. Biol. 234:231-243 (2001).
Krause et al., “Multi-Organ, Multi-Lineage Engraftment by a Single Bone Marrow-Derived Stem Cell,” Cell 105(3):369-377 (2001).
Kuehnle and Goodell, “The Therapeutic Potential of Stem Cells from Adults,” BMJ 325:372-376 (2002).
Lammert et al., “Induction of Pancreatic Differentiation by Signals from Blood Vessels,” Science 294:564-567 (2001).
Lawrence et al., “Differential Hepatocyte Toxicity of Recombinant Apo2L/Trail Versions,” Nature Medicine 7:383-385 (2001).
Markmann et al., “Indefinite Survival of MHC Class I-Deficient Murine Pancreatic Islet Allografts,” Transplantation 54(6):1085-1089 (1992).
Matsumoto et al., “Liver Organogenesis Promoted by Endothelial Cells Prior to Vascular Function,” Science 294:559-563 (2001).
Mayer -Proschel et al., “Isolation of Lineage-Restricted Neuronal Precursors from Multipotent Neuroepithelial Stem Cells,” Neuron 19:773-785 (1997).
McKay et al., “Mammalian Deconstruction for Stem Cell Reconstruction,” Nature Medicine 6:747-748 (2000).
Mezey et al., “Turning Blood into Brain: Cells Bearing Neuronal Antigens Generated In Vivo from Bone Marrow,” Science 290(5497):1779-1782 (2000).
Morrison, “Stem Cell Potential: Can Anything Make Anything?” Curr. Biol. 11:R7-R9 (2001).
Offield et al., “PDX-1 Is Required for Pancreatic Outgrowth and Differentiation of the Rostral Duodenum,” Development 122:983-995 (1996).
Petersen et al., “Bone Marrow as a Potential Source of Hepatic Oval Cells,” Science 284(5417)1168-1170 (1999).
Rabinovitch et al.,“TNF-α Down-Regulates Type 1 Cytokines and Prolongs Survival of Syngeneic Islet Grafts In Nonobese Diabetic Mice,” J. Immunol. 159: 6298-6303(1997).
Ramiya et al., “Reversal of Insulin-Dependent Diabetes Using Islets Generated in Vitro from Pancreatic Stem Cells,” Nature Medicine 6:278-282 (2000).
Rietze et al., “Purification of a Pluripotent Neural Stem Cell from the Adult Mouse Brain,” Nature 412(6848):736-739 (2001).
Roberts et al., “Hox11 Controls the Genesis of the Spleen,” Nature 368:747-749 (1994).
Rosenthal, N., “Prometheus's Vulture and the Stem-Cell Promise,” N. Engl. J. Med. 349(3): 267-274 (2003).
Ryu et al., “Reversal of Established Autoimmune Diabetes by Restoration of Endogenous Beta Cell Function,” J. Clin. Invest. 108(1):63-72 (2001).
Serup et al., “Islet and Stem Cell Transplantation for Treating Diabetes,” BMJ 322:29-32 (2001).
Serup, “Panning for Pancreatic Stem Cells,” Nature Genetics 25(2):134-135 (2000).
Shihabuddin et al., “Adult Spinal Cord Stem Cells Generate Neurons After Transplantation in the Adult Dentate Gyrus,” J. Neurosci. 20(23):8727-8735 (2000).
Slack, “Stem Cells in Epi
Belyavskyi Michail A
Clark & Elbing LLP
The General Hospital Corporation
LandOfFree
Methods and compositions for treating type 1 diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for treating type 1 diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for treating type 1 diabetes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4112016